Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
Australian public assessment report (AusPar) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (302)
2016 (34)
2015 (52)
2014 (32)

Search

Sponsor content

1423 result(s) found, displaying 1241 to 1250

APOTEX-PREGABALIN pregabalin 225 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 300 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 10mg tablet blisters Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 10mg tablet bottles Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 20mg tablet bottles Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 40mg tablet bottles Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/25 olmesartan medoxomil 40 mg & hydrochlorothiazide 25 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEM MART CEPHALEXIN cefalexin (as monohydrate) 125mg/5mL powder for suspension bottle Cancelled under s30(1)(c)

2 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 121
Page 122
Page 123
Page 124
Current page 125
Page 126
Page 127
Page 128
Page 129
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia